Enanta Pharmaceuticals (ENTA) Non Operating Income (2012 - 2026)
Enanta Pharmaceuticals (ENTA) reported Non Operating Income of -$2.23 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), compared with $667,000 a year earlier.
Powered by 
Analysis
Enanta Pharmaceuticals (ENTA) Non Operating Income (2012 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Enanta Pharmaceuticals' Non Operating Income came in at -$4.4 million; for FY2025 (ended Sep 30, 2025), it was $1.8 million, down 53.9% from FY2024.
- Non Operating Income has a five-year compound annual growth rate of -22.9% (FY2020 to FY2025).
- By fiscal year, Non Operating Income came in at $3.9 million in FY2024 (-37.2%), $6.21 million in FY2023 (+275.1%), $1.66 million in FY2022 (-17.0%) and $1.99 million in FY2021 (-69.9%).
- The fiscal Q3 2026 figure ranks as the lowest quarterly Non Operating Income in data going back to fiscal Q2 2012.
- The high point for year-over-year Non Operating Income in five years was fiscal Q2 2023 (growth of 620.4%); the low point was fiscal Q4 2021 (a decline of 71.0%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at -$1.23 million (Q2 2026), -$661,000 (Q1 2026) and -$282,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | -73.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 387.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Enanta Pharmaceuticals | 383.80 Mn | -344.19 Mn | - | -2.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2.23 Mn |
| Mar 31, 2026 | -1.23 Mn |
| Dec 31, 2025 | -661,000.00 |
| Sep 30, 2025 | -282,000.00 |
| Jun 30, 2025 | 667,000.00 |
| Mar 31, 2025 | 578,000.00 |
| Dec 31, 2024 | 837,000.00 |
| Sep 30, 2024 | 668,000.00 |
| Jun 30, 2024 | 1.13 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 857,000.00 |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 1.87 Mn |
| Mar 31, 2023 | 1.84 Mn |
| Dec 31, 2022 | 993,000.00 |
| Sep 30, 2022 | 714,000.00 |
| Jun 30, 2022 | 393,000.00 |
| Mar 31, 2022 | 255,000.00 |
| Dec 31, 2021 | 258,000.00 |
| Sep 30, 2021 | 333,000.00 |
API Access
Enanta Pharmaceuticals Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=ENTA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "ENTA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=ENTA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();